RAC1 and diabetic kidney disease: Notably, there was no difference in podocyte numbers between diabetic or nondiabetic mice at this stage of diabetic nephropathy, implying that podocyte were undergoing a relatively early and adaptive mutation rather than apoptosis under such diabetic conditions, which was partially reversible, as indicated in the present study, by Rac1 signaling deficiency.